Everest Medicines Signs $1.03 Billion Exclusive License Agreement with Travere for Civorebrutinib (EVER001) Development and Commercialization 12
Everest Medicines Signs Major Licensing Deal with Travere Th...
Sign in to continue:
Everest Medicines Signs Major Licensing Deal with Travere Th...
DL Holdings Group Limited Announces US\$5 Million Investment...
Henderson Investment Limited: EGM Poll Results and Approval ...
CSPC Pharmaceutical Group Announces Groundbreaking Clinical ...
CSPC Pharmaceutical Group: Key Highlights from Phase I Clini...
Agile Group Holdings Limited – May 2026 Unaudited Operating ...
Fujikon Industrial Holdings Announces Significant Reduction ...
AUX International Holdings Limited Announces Upcoming Board ...
InvesTech Holdings Limited: Completion of Placing of New Sha...
HKR International Limited Announces Upcoming Board Meeting f...